NCT01514045 The Gastric Cancer Foundation: A Gastric Cancer Registry
| NCT ID | NCT01514045 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stanford University |
| Condition | Gastric Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2011-04 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2011-04 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Gastric Cancer Registry will combine data acquired directly from patients with gastric cancer; with a family history of gastric cancer in a first or second degree relative; or persons with a known germline mutation in their CDH1 (E-Cadherin) gene via an online questionnaire with genomic data obtained from saliva, blood and tissue samples. The purpose of this registry is to gain better understanding of the causes of gastric cancer, both environmental and genetic; whether certain genomic data can predict outcomes of treatment and survival.
Eligibility Criteria
Inclusion Criteria: 1. Patients are eligible if they have a histologically proven gastric tumor including gastroesophageal tumors; OR they have a family history of gastric cancer in a first or second degree relative; OR persons with a known germline mutation in their CDH1 (E-Cadherin) gene. 2. 18 years of age or older 3. Adequate English proficiency to complete online consent and questionnaire. Spanish-language proficiency as an alternative to English-language proficiency. Exclusion Criteria: 1. Under 18 years of age 2. No history of gastric cancer or gastric cancer in a family member or a known germline mutation in their CDH1 gene.
Contact & Investigator
Hanlee P Ji, MD
PRINCIPAL INVESTIGATOR
Stanford University
Frequently Asked Questions
Who can join the NCT01514045 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Gastric Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01514045 currently recruiting?
Yes, NCT01514045 is actively recruiting participants. Contact the research team at GCRegistry@stanford.edu for enrollment information.
Where is the NCT01514045 trial being conducted?
This trial is being conducted at Stanford, United States.
Who is sponsoring the NCT01514045 clinical trial?
NCT01514045 is sponsored by Stanford University. The principal investigator is Hanlee P Ji, MD at Stanford University. The trial plans to enroll 500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.